Literature DB >> 7195661

Are convulsant gases also anesthetics?

D D Koblin, E I Eger, B H Johnson, P Collins, R C Terrell, L Speers.   

Abstract

This study investigated whether the convulsant gas flurothyl deviates from the correlation between anesthetic potency and lipid solubility. Flurothyl (CF3CH2OCH2CF3) produced convulsions in 50% of mice at 0.122 +/- 0.006% atm. Mice often convulsed repeatedly after exposure to flurothyl, the maximum number of convulsions occurring when the concentration was 0.24% atm. Concentrations greater than 0.6% atm produced convulsions immediately after addition of flurothyl, but rarely at later times. An ED50 value for loss of the righting reflex was obtained when the concentration was 1.22 +/- 0.19% atm. The oil/gas partition coefficient was found to be 46.9 for flurothyl at 37 C. The product of righting-reflex ED50 and oil/gas partition coefficient (0.0122 atm x 46.9 = 0.57 atm) is similar to that found for conventional anaesthetics in mice. Therefore, flurothyl does not deviate from the correlation of anesthetic potency and lipid solubility. It was also found that 0.3 to 0.8% atm flurothyl increased isoflurane MAC in dogs, but that 3 to 4% atm flurothyl decreased it. The increase of isoflurane requirement at lower concentrations of flurothyl suggests that anesthetics with a potential to cause convulsions may partly antagonize their own anesthetic effect. The decrease in isoflurane MAC in dogs at higher concentrations of flurothyl also implies that this compound has an anesthetic effect. A structural isomer of flurothyl, iso-Indoklon [(CSF3)2CHOCH3], was only anesthetic and did not have convulsant properties. Its MAC in dogs was 4.60 +/- 0.45% atm, and its righting-reflex ED50 in mice was 2.65 +/- 0.13% atm. The product of iso-Indoklon MAC in dogs and its oil/gas partition coefficient (27.0) was 1.24 atm, and the product of iso-Indoklon righting-reflex ED50 in mice and oil/gas partition coefficient was 0.72 atm. These values are close to those found for conventional anesthetic agents in dogs and mice; thus iso-Indoklon also does not deviate from the correlation between anesthetic potency and lipid solubilities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195661

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Contradicting a unitary theory of general anesthetic action: a history of three compounds from 1901 to 2001.

Authors:  Matthew D Krasowski
Journal:  Bull Anesth Hist       Date:  2003-07

2.  Clinical concentrations of chemically diverse general anesthetics minimally affect lipid bilayer properties.

Authors:  Karl F Herold; R Lea Sanford; William Lee; Olaf S Andersen; Hugh C Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

3.  Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels.

Authors:  M D Krasowski
Journal:  Neuropharmacology       Date:  2000-04-27       Impact factor: 5.250

4.  Positive and Negative Allosteric Modulation of an α1β3γ2 γ-Aminobutyric Acid Type A (GABAA) Receptor by Binding to a Site in the Transmembrane Domain at the γ+-β- Interface.

Authors:  Selwyn S Jayakar; Xiaojuan Zhou; Pavel Y Savechenkov; David C Chiara; Rooma Desai; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

5.  Alteration of lipid bilayer mechanics by volatile anesthetics: Insights from μs-long molecular dynamics simulations.

Authors:  Eric A Zizzi; Marco Cavaglià; Jack A Tuszynski; Marco A Deriu
Journal:  iScience       Date:  2022-02-18

6.  Anesthetic Alterations of Collective Terahertz Oscillations in Tubulin Correlate with Clinical Potency: Implications for Anesthetic Action and Post-Operative Cognitive Dysfunction.

Authors:  Travis J A Craddock; Philip Kurian; Jordane Preto; Kamlesh Sahu; Stuart R Hameroff; Mariusz Klobukowski; Jack A Tuszynski
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.